logo
Select company
Select metric
$ 81KNet Income to Non-Controlling Interests
VS
Market
82
Sector
93
Industry
98
History
74
$ 2.36Close
$ 2 - $ 2.7 52-Week Range
Ticker Information

Ticker

ORMP

Company Name

ORAMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ORAMED PHARMACEUTICALS INC - Net Income to Non-Controlling Interests Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ORMP - Net Inc. NCI Historical data
DateNet Income to Non-Controlling Interests
6/30/2025$ 81K
3/31/2025$ 45K
12/31/2024$ 43K
9/30/2024$ 801K
6/30/2024$ 762K
3/31/2024$ 651K
12/31/2023$ 437K
9/30/2023$ 1.82M
6/30/2023$ 1.69M
3/31/2023$ 1.27M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ORAMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) Net Inc. NCI stands at $ 0.
  • Over the past 5 years, ORAMED PHARMACEUTICALS INC's average Net Inc. NCI has been $ 448.5K.
  • The median Net Inc. NCI for ORAMED PHARMACEUTICALS INC during this period was $ 490K
  • ORAMED PHARMACEUTICALS INC reached its highest Net Inc. NCI over the past 5 years at $ 1.82M.
  • The lowest Net Inc. NCI recorded by ORAMED PHARMACEUTICALS INC in the same timeframe $ -1.6M

ORAMED PHARMACEUTICALS INC's Net Inc. NCI vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. NCI Benchmarks
CompanyNet Inc. NCI
NTRB : NUTRIBAND INC $ 0OTLK : OUTLOOK THERAPEUTICS INC $ 0CNTB : CONNECT BIOPHARMA HOLDINGS LTD $ 0PYXS : PYXIS ONCOLOGY INC $ 0BTAI : BIOXCEL THERAPEUTICS INC $ 0VTGN : VISTAGEN THERAPEUTICS INC $ 0DTIL : PRECISION BIOSCIENCES INC $ 0LGVN : LONGEVERON INC $ 0PLUR : PLURI INC $ -667KADVM : ADVERUM BIOTECHNOLOGIES INC $ 0

Definition of Net Income to Non-Controlling Interests

[Income Statement] The portion of income which is attributable to non-controlling interest shareholders; subtracted from [ConsolInc] in order to obtain [NetInc].

ORMP - Net Income to Non-Controlling Interests, Last 5 years

$ -1.6M

Minimum

Sep 30, 2022

$ 1.82M

Maximum

Sep 30, 2023

$ 448.5K

Average

$ 490K

Median

Net Inc. NCI Benchmark Analysis

The chart above depicts the distribution of Net Inc. NCI for companies in the Total Stock Market. The average Net Inc. NCI of the companies is $ 11.12M with a standard deviation of $ 136.5M.
The following table provides additional summary stats:
Net Inc. NCI in the Market:
filtered constituents4.26K
min$ -1.8B
max$ 2.94B
average$ 11.12M
median$ 0
std$ 136.5M